Related Experiment Video

Updated: May 28, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

Follow up of phenylketonuria patients

M Demirkol1, M Giżewska, M Giovannini

  • 1Div Nutrition and Metabolism, Children's Hospital, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey. demirkolm@istanbul.edu.tr

Molecular Genetics and Metabolism
|October 25, 2011
PubMed

Insights

Lifelong blood phenylalanine control is crucial for phenylketonuria (PKU) patients

Area of Science:

  • Metabolic disorders and genetic conditions.

Background:

  • Phenylketonuria (PKU) management requires lifelong blood phenylalanine (phe) control for optimal neuropsychological outcomes.
  • Adolescents and young adults face challenges in adhering to PKU follow-up strategies.
  • Emerging therapies may alleviate the strict dietary phe restrictions for PKU patients.

Purpose of the Study:

  • To review and update PKU follow-up guidelines.
  • To address critical aspects of PKU management, including nutrition, metabolic control, and long-term health.
  • To improve the transition to adulthood for individuals with PKU.

Main Methods:

  • Review of current PKU follow-up policies and recent therapeutic advancements.
  • Analysis of challenges in patient compliance and long-term management.
  • Identification of unmet needs in the PKU population.

Main Results:

  • Understanding of lifelong phe control's importance for neuropsychological outcomes has grown.
  • Compliance remains a significant challenge, particularly in adolescents and young adults.
  • New therapies offer potential to reduce dietary burdens.

Conclusions:

  • Revisiting PKU follow-up guidelines is timely to incorporate new knowledge and therapies.
  • Guidelines should address breastfeeding, metabolic control, nutritional biomarkers, neurocognitive and psychological assessments, bone health, and adult transition.
  • Addressing unmet needs is essential for improving PKU patient outcomes.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...